New Phase 2 Trial Boosts Stage III NSCLC Treatment
In a groundbreaking effort to enhance the treatment landscape of stage III non-small cell lung cancer (NSCLC), researchers have recently ...
Tag: chemo-immunotherapy
NADIM ADJUVANT Trial Highlights Advantages of Chemo-Immunotherapy After Surgery in Stage IB–IIIA NSCLC
Interim findings from the NADIM ADJUVANT Phase III clinical trial conducted by the Spanish Lung Cancer Group (GECP) have unveiled ...
Chemo-Immunotherapy Exhibits Promising Efficacy in Advanced HPV-Negative Head and Neck Cancer Patients
Researchers at the University of Chicago Medicine Comprehensive Cancer Center are redefining the therapeutic landscape for advanced head and neck ...
